Alport Syndrome Panel | NGS

Genes SequencedCOL4A3, COL4A4, COL4A5
Test DetailsExtraction of DNA, capture of the genes to be assayed, and sequencing on the Illumina platform. Identified variants are categorized as pathogenic, likely pathogenic, variant of uncertain significance, likely benign, or benign. An interpretation of results is provided based on the medical literature and in the context of the indication for testing. aCGH send out testing for the COL4A5 gene is performed when NGS does not identify any pathogenic or likely pathogenic variants.
MethodologyNext-generation sequencing
PerformedMonday – Friday
Turnaround3 – 4 weeks
Specimen RequirementsPeripheral blood or Buccal swabs
Sample Collection1 EDTA (lavender top) tube containing 2-5 mL peripheral blood or 2-4 buccal swabs
Minimum Sample Volume1 ml; 2 swabs
Storage/Transport ConditionsAmbient/room temperature preferred. However, if delivery/shipment of specimen is greater than four (4) hours, refrigerate at 4 degrees until delivery/shipment by overnight delivery. In seasonal warmer weather, include cold pack (DO NOT FREEZE).
Unacceptable ConditionsFrozen specimens, clotted or hemolyzed specimens, inappropriate tube type
CPT Code(s)81407 x 1 (NGS) and 81479 x 1 (aCGH send out)
Requisition